These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23627934)

  • 1. Functionalized mesoporous silica nanoparticles: a possible strategy to target cancer cells reducing peripheral nervous system uptake.
    Ceresa C; Nicolini G; Rigolio R; Bossi M; Pasqua L; Cavaletti G
    Curr Med Chem; 2013; 20(20):2589-600. PubMed ID: 23627934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
    Tao Z; Toms B; Goodisman J; Asefa T
    ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
    Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
    J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H; Chen W; Xu ZP; Qian G; An J; Zhang H
    Chemistry; 2017 Aug; 23(45):10878-10885. PubMed ID: 28580592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
    Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
    Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin.
    Alvarez-Berríos MP; Vivero-Escoto JL
    Int J Nanomedicine; 2016; 11():6251-6265. PubMed ID: 27920531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
    Liu Q; Zhang J; Xia W; Gu H
    Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
    van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
    ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.
    Pasqua L; Leggio A; Sisci D; Andò S; Morelli C
    Mini Rev Med Chem; 2016; 16(9):743-53. PubMed ID: 26996622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized Silica Nanoparticles As an Alternative Platform for Targeted Drug-Delivery of Water Insoluble Drugs.
    de Oliveira LF; Bouchmella K; Gonçalves Kde A; Bettini J; Kobarg J; Cardoso MB
    Langmuir; 2016 Apr; 32(13):3217-25. PubMed ID: 26930039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.